Skip to content

Microcirculation Guided Therapy Versus Standard Treatment of Severe Sepsis

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00484133
Enrollment
80
Registered
2007-06-08
Start date
2007-06-30
Completion date
Unknown
Last updated
2008-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Sepsis, Microcirculation

Keywords

sepsis, severe sepsis, microcirculation, Orthogonal polarisation spectral

Brief summary

The purpose of this study is to asses the recovery of organ failure between two resuscitation protocols in severe sepsis: standard, pressure guided therapy versus a microcirculation guided therapy

Detailed description

Despite continued improvements in medical therapy, mortality from septic shock has remained between 30% and 70% for the past three decades with only a slight decrease in mortality rate. Standard treatment of septic shock is fluid resuscitation, followed by agents with vasopressor activity to correct hypotension in septic shock. The question rises whether vasopressors should be the first line of action in septic shock Opening and recruiting the microcirculation are expected to improve regional organ function and tissue distress in severe sepsis. Beside fluid resuscitation, vasodilatation, in this respect, enhances microcirculatory flow while vasoconstriction causes a reduction in microcirculatory flow. On the other hand, a minimal perfusion pressure should be present. Our aim is to asses the effects of two resuscitation protocols in severe sepsis: the standard treatment using predefined pressure goals versus a microcirculation guided therapy.

Interventions

DRUGDopamine
DRUGdobutamine

Sponsors

Onze Lieve Vrouwe Gasthuis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age 18 years or older * admission to the intensive care unit with severe sepsis, defined in according with a modification of the American College of Chest Physician/SCCM guidelines criteria * intention to provide full intensive care treatment for at least 72 hours and * written informed consent to be obtained from patient or next of kin.

Exclusion criteria

* haematologic malignancy * metastatic malignancy * AIDS with CD4 \< 50 cells/mm3 * liver cirrhosis Child Pugh B & C * pregnancy * post resuscitation with GCS \< 8 of 15 and treatment with induced hypothermia

Design outcomes

Primary

MeasureTime frame
Difference in SOFA (Sequential Organ Failure Assessment) score during the first 72 hours of treatment for severe sepsis72 hours

Secondary

MeasureTime frame
ICU and hospital length of stayhospital stay
ICU and hospital mortalityhospital stay
Duration of organ supportduring ICU treatment
Plasma concentration of asymmetric dimethyl arginine (ADMA72 hours
Severity, decrease and duration of organ failure over the complete ICU staycomplete icu stay
Inflammatory response measured by IL-6/IL-1072 hours

Countries

Netherlands

Contacts

Primary ContactRutger v Raalte, MD
R.vanRaalte@olvg.nl0031205993007
Backup ContactPeter vd Voort, MD
P.H.J.vanderVoort@olvg.nl0031205993007

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026